This Benzene Chemicals Stock Rises 23% in 1 Year: A Recovery From a Very Weak Base

This benzene chemicals stock has risen approximately 23% in the twelve months to 18 September 2026, from a close of Rs 390.90 to Rs 482.40. The base, though, was the weakest this benzene chemicals stock had seen in five years.

The company is Aarti Industries Ltd (NSE: AARTIIND), the Vapi headquartered maker of benzene, toluene and chlorine derivatives for agrochemical, pharmaceutical and fuel additive customers. The Aarti Industries share price fell through most of 2025, bottomed at Rs 338.05 on 21 January 2026, and has recovered on four quarters of margin repair.

Click Here – Get Free Investment Predictions

Benzene Chemicals Stock Returns: What the One-Year Number Says

The gain is genuine price appreciation. There was no split and no bonus issue in the window, and face value remains Rs 5. The verified close-to-close return on this benzene chemicals stock is 23.41%.

Here is how the benzene chemicals stock has performed across windows verified from daily closes:

Period	Base Close (Rs)	Price on 18 Sep 2026 (Rs)	Return
1 Month	530.10	482.40	-9.0%
6 Months	432.90	482.40	+11.4%
1 Year	390.90	482.40	+23.4%
3 Years	511.95	482.40	-5.8%

The shape of that table is the story. Over three years this benzene chemicals stock is still down about 6%, and it has given back 9% in the last month. The twelve month gain sits inside a longer drawdown, not on top of a trend.

The 52-week range runs from Rs 338.05 on 21 January 2026 to Rs 551.75 on 25 August 2026. At Rs 482.40 the benzene chemicals stock sits roughly 43% above the low and 13% below the high. It was among the better performers on a screen of NSE small-cap stocks ranked by 1-year return, dated 18 September 2026.

Why Did This Benzene Chemicals Stock Rise 23% in One Year?

The short answer is margin repair. Operating margin bottomed at 11.57% in the June 2025 quarter and climbed every quarter since, reaching 14.73% in June 2026, while quarterly net profit went from Rs 43 crore to Rs 155 crore. Four dated events did the work in this benzene chemicals stock.

6 November 2025: The Downgrade Cycle Broke

September 2025 quarter results landed on 6 November 2025. Revenue was approximately Rs 2,250 crore, up roughly 30% year on year, with EBITDA of Rs 291 crore and net profit of Rs 106 crore, roughly double the year-ago figure.

On 7 November 2025 around 19.4 million shares traded against a normal day nearer 500,000, and the Aarti Industries share price swung between Rs 384.10 and Rs 419.50. It was the first quarter in two years that beat rather than missed.

3 February 2026: A 15% Single-Day Jump in This Benzene Chemicals Stock

December 2025 quarter numbers arrived ahead of the 3 February 2026 session. Revenue was approximately Rs 2,494 crore, EBITDA Rs 323 crore and net profit Rs 133 crore. This benzene chemicals stock opened at Rs 443 against a previous close of Rs 373 and finished at Rs 429.70.

That single session accounts for a large share of the full year return in this benzene chemicals stock, and it came nine trading days after the 52-week low.

12 March 2026: A USD 150 Million Contract Running to 2030

On 12 March 2026 the company disclosed a medium-term supply agreement worth approximately USD 150 million with a global agrochemical innovator, running to 31 March 2030, turning an existing relationship into contracted volumes for this benzene chemicals stock.

The Aarti Industries share price rose about 6% that day, touching Rs 456.75 intraday while the broader market fell. Long term contracts matter more than usual for a benzene chemicals stock, because contracted volumes shield part of the book from spot competition.

31 July 2026: The June Quarter Confirmed the Repair

June 2026 quarter results came on 31 July 2026. Revenue was approximately Rs 2,627 crore, up 41% year on year, EBITDA rose 79% to Rs 385 crore and net profit climbed to Rs 155 crore. Management credited product mix, inventory management and forex gains rather than volume growth, still under pressure in this benzene chemicals stock.

The shares touched Rs 516.95 intraday that day and set the 52-week high of Rs 551.75 on 25 August 2026. This benzene chemicals stock has since drifted back into the Rs 470 to Rs 500 band.

Check the Univest Screener for Live Fundamentals of High-Return Stocks

Aarti Industries Share Price and the Benzene Derivatives Chain

Behind this benzene chemicals stock sit chlorination, nitration, ammonolysis and hydrogenation platforms across 16 plants in Gujarat and Maharashtra. The company describes itself as the largest Indian producer in several benzene derivative chains, including dichlorobenzene and nitrochlorobenzene.

Energy and additives, about 38% of June 2026 quarter revenue, is almost entirely export driven, polymers and additives is also export heavy, and pharmaceutical intermediates is the most domestic. That tilt is why freight and geopolitics hit this benzene chemicals stock directly, and management flagged West Asia disruption in the June quarter.

It also explains the Chinese pressure on the benzene chemicals stock. Chinese producers expanded capacity in exactly these chains and exported surplus at prices Indian producers struggle to match. On 13 August 2024 the company withdrew its FY25 EBITDA guidance of Rs 1,450 crore to Rs 1,700 crore, blaming dumping from China and rising benzene and aniline costs. The Aarti Industries share fell about 16% that day, and FY25 EBITDA finished at Rs 1,017 crore.

One China dependency cuts the other way for this benzene chemicals stock. Aniline, a key input for energy additives, is largely imported from China, so lower priced Chinese aniline helps the input line even as Chinese finished goods hurt the output line.

The Financial Record Behind This Benzene Chemicals Stock

Revenue, EBITDA and profit have risen for four consecutive quarters in this benzene chemicals stock, and operating margin has widened by more than 300 basis points from the trough.

Quarter	Revenue (Rs Cr)	EBITDA (Rs Cr)	Net Profit (Rs Cr)	Operating Margin
Jun 2025	1,871	216	43	11.57%
Sep 2025	2,250	291	106	13.91%
Dec 2025	2,494	323	133	12.36%
Mar 2026	2,423	342	137	14.12%
Jun 2026	2,630	385	155	14.73%

The annual picture needs honesty. FY26 revenue was approximately Rs 8,291 crore with EBITDA of Rs 1,179 crore and net profit of Rs 419 crore, against Rs 7,287 crore, Rs 1,017 crore and Rs 331 crore in FY25. Both sit far below FY22, when the company earned Rs 1,186 crore at a 25.05% operating margin.

Revenue has grown about 36% since FY22 while net profit has fallen roughly 65%, and operating margin has halved to 13.07%. Earnings per share went from Rs 32.71 in FY22 to Rs 9.12 in FY25 and Rs 11.55 in FY26. Two years of earnings downgrades created the weak base this benzene chemicals stock is recovering from.

Capital spending explains much of the decline in returns on this benzene chemicals stock. More than Rs 5,500 crore has gone in since 2019, and return on capital employed fell to 6.6% in FY25 from 17.2% in FY19. Trailing return on equity is approximately 7.04%, and FY27 capex is guided at Rs 700 crore to Rs 800 crore.

Shareholding in This Benzene Chemicals Stock

Ownership has shifted slowly across five quarters.

Quarter	Promoters	FII	DII	Public
Jun 2025	42.24%	6.44%	20.38%	30.94%
Sep 2025	42.18%	6.40%	18.21%	33.20%
Dec 2025	42.14%	6.69%	18.22%	32.95%
Mar 2026	42.09%	7.38%	20.12%	30.40%
Jun 2026	41.82%	6.99%	21.11%	30.07%

Domestic institutions moved from 18.21% in September 2025 to 21.11% in June 2026, with a state-owned insurer at 6.80%. That is meaningful buying into the recovery in this benzene chemicals stock. Promoter holding slipping to 41.82% is a mild negative, but the founding family remains the anchor.

Risks in This Benzene Chemicals Stock

Chinese oversupply has not gone away. The margin recovery came from mix, inventory and forex rather than volume or pricing power, as management stated in July 2026. If Chinese export pricing tightens again, the gains in this benzene chemicals stock reverse quickly.

Debt is elevated and the credit outlook on this benzene chemicals stock is negative. Debt to equity is approximately 0.83, up from 0.68 in FY22, and a rating agency moved its long-term outlook to negative from stable on 11 September 2025, expecting gross debt to EBITDA near 3.5 times in FY26 on roughly Rs 2,800 crore of capex across FY25 to FY27.

Project execution has slipped. Zone IV and the chlorotoluene value chain are delayed roughly four to six months by a contract labour shortage and will be commissioned in phases over three quarters. Each quarter of delay pushes out revenue meant to service the debt raised to build them.

Raw material pass-through is slow. Benzene and aniline prices rose sharply through the March 2026 quarter and agrochemical contracts can take three to six months to reprice. A fresh input spike would hit this benzene chemicals stock the way it did in 2024.

Liquidity and volatility are real constraints. This benzene chemicals stock is not in the NSE derivatives segment, so positions cannot be hedged with listed futures or options, and daily volumes swing from around 300,000 shares to over 19 million on news days. Single-session moves of 15% on 3 February 2026 and 13% on 15 June 2026 show what that means. On 15 June 2026 the company told the exchanges the volume spike was market driven, not news.

Finally, the FY28 EBITDA target of Rs 1,800 crore to Rs 2,200 crore implies roughly a doubling from FY26. Guidance was withdrawn once before, in August 2024, so the discount applied to that target in this benzene chemicals stock is earned.

Download the Univest iOS App or Univest Android App to track the Aarti Industries share price live

Aarti Industries Share: Analyst View

Analyst opinion on the Aarti Industries share has been split for two years, and the split is about valuation rather than the recovery. The question is whether a trailing price to earnings ratio of approximately 32.55, against an industry figure near 36.35, is low enough given return on equity of 7.04%.

A domestic brokerage carried a sell rating through the August 2024 collapse, then a buy rating followed the February 2026 results. This is a cyclical benzene chemicals stock where the direction is agreed and the price is not.

Aarti Industries Share Price Target

The most recent verified Aarti Industries share price target in published research is Rs 530, issued by a domestic brokerage on 4 February 2026. That is approximately 10% above Rs 482.40 and below the Rs 551.75 high this benzene chemicals stock printed in August 2026.

That Aarti Industries share price target predates both the June 2026 quarter and the August 2026 rally. Working from levels instead, Rs 551.75 is the ceiling and Rs 338.05 the floor, and the Aarti Industries share price has spent September 2026 between roughly Rs 468 and Rs 525.

Other Stocks to Track From the Same Return Screen

Beyond this benzene chemicals stock, a screen of NSE small-cap stocks ranked by 1-year return also includes related names such as Morepen Labs with a 1-year return of 99.55%, Shivalik Bimetal at 99.14% and RR Kabel at 93.99%.

Among the names covered from that screen, MTAR Technologies returned 396.53% over one year. Readers can compare this benzene chemicals stock with the Nifty 50 benchmark and track each of these names on Univest before making any decision.

Conclusion

A 23% twelve month gain in this benzene chemicals stock is a recovery, not a re-rating. Margins bottomed in June 2025, four quarters of improvement followed, and quarterly profit is Rs 155 crore against Rs 43 crore fifteen months ago.

Equally real is that the three year return is negative, FY26 profit is roughly a third of FY22, return on equity is approximately 7% and the credit outlook is negative. The Aarti Industries share price is being paid for a recovery that has started but is not finished.

The next checkpoint is near. Zone IV and chlorotoluene are due on stream in phases, and September 2026 quarter numbers will show whether volume growth has joined the margin recovery in this benzene chemicals stock.

Frequently Asked Questions

Which benzene chemicals stock rose 23% in one year?

Ans. Aarti Industries Ltd (NSE: AARTIIND) rose approximately 23% in the year to 18 September 2026, from Rs 390.90 to Rs 482.40. It makes benzene, toluene and chlorine derivatives for agrochemical, pharmaceutical and fuel additive customers.

Why did the Aarti Industries share price rise in the last year?

Ans. Margin recovery drove the gain in this benzene chemicals stock. Operating margin improved from 11.57% in June 2025 to 14.73% in June 2026, quarterly profit rose from Rs 43 crore to Rs 155 crore, and a USD 150 million contract signed on 12 March 2026 added visibility to 2030.

What were Aarti Industries June 2026 quarter results?

Ans. Revenue was approximately Rs 2,627 crore, up 41% year on year, in this benzene chemicals stock. EBITDA rose 79% to Rs 385 crore and net profit reached Rs 155 crore against Rs 43 crore.

How has Chinese dumping affected this benzene chemicals stock?

Ans. Chinese overcapacity in benzene derivatives pushed export prices down and forced the company to withdraw its FY25 EBITDA guidance of Rs 1,450 crore to Rs 1,700 crore on 13 August 2024. The shares fell about 16% that day.

Is Aarti Industries profit still below its earlier peak?

Ans. Yes. FY26 net profit of Rs 419 crore is roughly a third of the Rs 1,186 crore earned in FY22, and operating margin has halved from 25.05% to 13.07%.

What is the Aarti Industries share price target?

Ans. The most recent verified Aarti Industries share price target in published research is Rs 530, set by a domestic brokerage on 4 February 2026 with a buy rating, roughly 10% above Rs 482.40. A target is an estimate, not an assured outcome.

What is the 52-week high and low of Aarti Industries?

Ans. The 52-week high is Rs 551.75, set on 25 August 2026, and the low is Rs 338.05, set on 21 January 2026. The Aarti Industries share traded at Rs 482.40 on 18 September 2026, about 13% below the high.

What are the main risks in this benzene chemicals stock?

Ans. The biggest risks are renewed Chinese price competition, debt to equity of approximately 0.83 with a negative credit outlook assigned in September 2025, project delays of four to six months at Zone IV, and single-day price swings of 15% and 13% in the past year.